Advertisement

Topics

Sanofi-Aventis Biotech Company Profile

08:23 EDT 24th September 2017 | BioPortfolio

Just like scientists working in industry, universities and research institutions, students are required to submit a project outline describing their proposed research to a scientific evaluation committee. Students whose projects are approved may receive up to $200 in funding to help pay for equipment, supplies and other costs. For approved projects, the proposal evaluation committee will attempt to suggest the name(s) of potential mentors from the local biotechnology who may be able to provide students with access to research materials, expert advice and some of the supplies and equipment required to carry out their projects. In some, but not all regions, there are two different categories for students - Open Competition (grades 9 to 12) and Junior Competition (grades 7 & 8)

Location

B&D Consulting 805 15th Street, NWSuite 700
Washington
District of Columbia
20005
United States of America

Contact

Phone: 202.312.7400
Fax: 202.312.7460
Email: info@cberc.ca ., cbrown@genesis.mun.ca


News Articles [3826 Associated News Articles listed on BioPortfolio]

Sanofi to buy vaccines biotech group Protein Sciences

PARIS (Reuters) - French drugmaker and healthcare group Sanofi is to buy privately-held U.S vaccines biotech company Protein Sciences for an initial amount of $650 million, as Sanofi steps up its acqu...

#news #biotech Sanofi and Regeneron to end antibody R&D pact by year’s end

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sanofi and Regeneron to end antibody R&D pact by year’s end .Tucked aw...

More News! Sanofi’s HIV Treatment, German Biotech takes on Flu

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week. Atriva received €3M as a milestone from its investors for a preclin...

Sanofi Completes Protein Sciences Buy

Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal enhances the presence of Sa...

Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies

Ablynx and Sanofi have entered a research collaboration and exclusive licensing agreement for up to eight nanobody candidates for immune and inflammatory disease.  Ablynx, based in Belgium, develops...

Sanofi completes acquisition of vaccines biotech company

Sanofi has announced the completion of its acquisition of a privately-held US vaccines biotech company, Protein Sciences, following Federal Trade Commission approval.

#news #biotech Ablynx adds Sanofi to its list of pharma partners

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ablynx adds Sanofi to its list of pharma partners . from European Biotechnolo...

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinsen

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinse Die französische Sanofi (ISIN: FR0000120578) belegt mit über 100.000 Mitarbeitern in mehr als 100 Ländern und einem Umsatz von knapp 3....

PubMed Articles [71 Associated PubMed Articles listed on BioPortfolio]

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.

To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME).

Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for c...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

Acknowledgement to referees.

First-quarter biotech job picture.

Clinical Trials [101 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

SPECIFIC AIM: To test the safety and feasibility of using low molecular weight heparin (LMWH, enoxaparin sodium; Lovenox, Sanofi-Aventis) in lieu of unfractionated heparin (UFH) as antith...

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

To evaluate the pharmacokinetics of the thromboprophylactic agent enoxaparin in postoperative cardiac surgery patients by comparing plasma anti-Xa activity when enoxaparin is administered ...

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

A randomized, double-blind, placebo-controlled parallel-group study, comparing the bioequivalence of triamcinolone acetonide aqueous nasal spray (Apotex, Inc.) to that of Nasacort® AQ nas...

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

The primary objective of the study is to determine whether eszopiclone (Eurofarma) is non-inferior to the reference drug zopiclone (Imovane®, Sanofi-Aventis) in the treatment of insomnia.

Companies [941 Associated Companies listed on BioPortfolio]

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SA...

Merck and sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Pa...

Sanofi SA

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

More Information about "Sanofi-Aventis Biotech" on BioPortfolio

We have published hundreds of Sanofi-Aventis Biotech news stories on BioPortfolio along with dozens of Sanofi-Aventis Biotech Clinical Trials and PubMed Articles about Sanofi-Aventis Biotech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi-Aventis Biotech Companies in our database. You can also find out about relevant Sanofi-Aventis Biotech Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record